Star Sports Medicine Co., Ltd. (HKG:1609)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
210.00
+6.00 (2.94%)
May 27, 2026, 4:09 PM HKT

Star Sports Medicine Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.050.050.050.020.040.04
Debt / EBITDA Ratio
0.220.220.200.130.28-
Debt / FCF Ratio
0.270.270.340.130.232.09
Net Debt / Equity Ratio
-0.83-0.83-0.87-0.93-0.93-0.88
Net Debt / EBITDA Ratio
-3.54-3.54-3.80-5.82-7.191.78
Net Debt / FCF Ratio
-4.13-4.13-6.11-5.58-5.53-42.14
Asset Turnover
0.580.580.610.600.470.41
Inventory Turnover
1.711.712.061.851.490.98
Quick Ratio
4.444.443.565.094.995.54
Current Ratio
5.045.044.115.755.566.39
Return on Equity (ROE)
25.35%25.35%22.55%17.38%15.64%-77.66%
Return on Assets (ROA)
11.96%11.96%11.44%7.83%6.85%-40.59%
Return on Invested Capital (ROIC)
144.99%144.99%200.64%187.96%138.78%-422.08%
Return on Capital Employed (ROCE)
20.90%20.90%20.00%13.10%11.80%-47.80%
Buyback Yield / Dilution
---0.09%25.06%--
Source: S&P Global Market Intelligence. Standard template. Financial Sources.